Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Shareholder vote
confidence 95%
filed 2026-06-12
EX-99.1
The exhibit announces results of an extraordinary general meeting held on June 12, 2026, where shareholders approved two key resolutions: (1) a 35-for-1 share consolidation affecting both Class A and Class B ordinary shares, and (2) amendment and adoption of new memorandum and articles of association to reflect the consolidation. This is a direct disclosure of shareholder vote results on material corporate actions, matching the shareholder_vote_results taxonomy entry.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-12
Item 5.02
The filing discloses results of an annual stockholder meeting held on June 9, 2026, with detailed voting outcomes on five proposals: election of five directors (Nicolas Cary, Tucker Highfield, Evan Sohn, Manuel Stotz, and Kevin Wilson), ratification of Grassi & Co. as independent auditor, advisory vote on named executive officer compensation, approval of the 2026 Equity Incentive Plan, and approval of an amendment to the 2019 Plan to increase available shares. This is a classic Item 5.07 shareholder vote results disclosure with complete voting tallies and quorum information (74.91% voting power represented).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-12
The filing discloses results of an annual stockholder meeting held June 12, 2026, with voting outcomes on five proposals: election of directors (Keith A. Goldan and Bernhardt G. Zeiher, M.D.), advisory vote on named executive officer compensation, ratification of Deloitte & Touche LLP as auditor, approval of increased equity plan shares (8.4M to 11.5M), and a failed amendment to remove advance notice provisions for director nominations. This is a classic Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-12
The filing discloses results of an annual stockholder meeting held on June 11, 2026, under Item 5.07. The company reports voting outcomes for three matters: election of six directors (with detailed vote tallies for each nominee), ratification of Eide Bailly LLP as independent auditor, and approval of a certificate amendment to increase authorized common shares to 35,000,000. All three proposals passed with substantial majorities, making this a standard shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
The filing discloses results of Neuraxis, Inc.'s annual meeting of stockholders held on June 10, 2026, under Item 5.07. It reports voting outcomes for four matters: election of six directors (all approved with >96% support), ratification of auditor Rosenberg Rich Baker Berman, P.A., amendment to the 2022 Omnibus Securities and Incentive Plan, and approval of the 2025 Employee Stock Purchase Plan. These are routine but material shareholder governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
The 8-K discloses results of AST SpaceMobile's Annual Meeting held on June 12, 2026, under Item 5.07. The filing reports voting outcomes on three proposals: (i) election of 10 directors, (ii) ratification of KPMG LLP as independent auditor, and (iii) advisory vote on named executive officer compensation. All three proposals passed with substantial majorities, and the detailed vote tallies are provided for each director and proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from Warby Parker's June 8, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes for three proposals: election of three Class II directors (Dave Gilboa, Youngme Moon, and Ronald Williams), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Evolus's Annual Meeting of Stockholders held on June 11, 2026. The filing presents voting outcomes for three proposals: election of Class II directors (Brady Stewart and Vikram Malik), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with majority support, and the detailed vote tallies (For/Against/Abstain/Broker Non-Vote) are the core content of the disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of TheRealReal's June 10, 2026 annual meeting of stockholders. The filing presents voting outcomes for six proposals: election of Class I directors (Caretha Coleman, Karen Katz, Mark McCaffrey), ratification of KPMG LLP as auditor, advisory vote on named executive officer compensation, and three failed management proposals to amend the Certificate of Incorporation. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) are the hallmark of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This Item 5.07 disclosure reports the results of Summit Therapeutics' 2026 Annual Meeting of Stockholders held on June 10, 2026, with detailed voting tabulations for four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, non-binding advisory vote on named executive officer compensation, and approval of a stock incentive plan amendment to increase shares by 8,000,000. All proposals were approved by the requisite stockholder vote, making this a clear shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder voting results from ZipRecruiter's June 9, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports final voting tallies on three proposals: election of directors (Brie Carere and Mike Gupta), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-12
EX-99.1
This exhibit is a formal Report of Voting Results filed pursuant to National Instrument 51-102 Section 11.3, disclosing the results of Aya Gold & Silver Inc.'s annual shareholders' meeting held on June 12, 2026. It tabulates voting outcomes for three resolutions: election of eight directors, appointment of KPMG LLP as auditors, and an advisory vote on executive compensation. The document explicitly states it is furnished "in accordance with section 11.3 of NI 51-102," confirming it is a mandatory shareholder-vote-results disclosure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-12
EX-99.1
This press release discloses the results of Aya Gold & Silver's annual general meeting of shareholders held on June 12, 2026. It reports detailed voting results for the election of eight director nominees (all approved), the appointment of KPMG LLP as auditors, and an advisory vote on executive compensation. The disclosure includes vote counts and percentages for each director and resolution, which is the core content required for shareholder_vote_results classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from the June 10, 2026 Annual Meeting of Stockholders, including election of two Class II directors, ratification of auditors, approval of convertible note issuance and warrant conversion rights, and adjournment authority. The filing directly reports voting outcomes with vote counts for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
Shareholders voted at the June 11, 2026 annual meeting on three matters: election of two Class I directors (Victor K. Lee and Jeff Zhou), ratification of Ernst & Young LLP as independent auditor, and advisory approval of 2025 named executive officer compensation. Detailed voting tallies including for, against, withheld, abstentions, and broker non-votes were disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Fortrea Holdings' 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports voting outcomes on three proposals: election of directors (Anshul Thakral, Peter M. Neupert, and William J. Sharbaugh), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies (For, Against, Withheld, Abstained, Broker Non-Votes) are characteristic of Item 5.07 disclosures and are material to investors assessing board composition and governance outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from ACM Research's 2026 Annual Meeting held on June 10, 2026. The filing reports voting outcomes for two proposals: election of four directors (David H. Wang, Haiping Dun, Tracy Liu, and Charles Pappis) and ratification of Ernst & Young Hua Ming LLP as independent auditor for 2026. All four director nominees were elected and the auditor appointment was ratified by substantial majorities, making this a routine but material governance disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
Camp4 held its Annual Meeting of Stockholders on June 10, 2026, with shareholders voting on three proposals: election of three Class II directors (Steven Holtzman, Murray Stewart, and Richard Young), ratification of Ernst & Young LLP as independent auditor, and approval of an amendment to the 2024 Equity Incentive Plan to modify the evergreen provision to include pre-funded warrants in the share calculation. All three proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder voting results from Comcast's June 10, 2026 annual meeting, covering four proposals: director elections, auditor ratification, advisory compensation vote, and an independent chair proposal. Item 5.07 explicitly requires disclosure of shareholder vote results, and the detailed vote tallies for each proposal constitute material information affecting investor assessment of corporate governance and management accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from GPGI's 2026 Annual Meeting held on June 11, 2026. The filing reports voting outcomes on four proposals: election of four Class II directors, advisory Say-on-Pay approval, Say-on-Frequency determination (annual voting approved), and auditor ratification. All proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and executive compensation oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Hagerty's 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing presents voting outcomes for four proposals: election of nine directors (all receiving majority affirmative votes), advisory approval of named executive officer compensation, advisory frequency vote on compensation (one year recommended), and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies and broker non-votes are characteristic of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Asana's June 8, 2026 Annual Meeting of Stockholders, covering three proposals: election of three Class III directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents the final vote tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Ginkgo Bioworks' 2026 annual meeting of shareholders held on June 11, 2026. The filing presents detailed voting results for three proposals: election of six directors (with separate voting by Class A and Class B shareholders), ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they determine board composition and affirm key governance decisions.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-12
EX-99
This exhibit discloses the results of the Company's Annual General Meeting held on June 9, 2026, with detailed voting outcomes on four resolutions: cancellation of Ms. Jannu Binti Babjan's directorship, appointment of Mr. Uwe Henke von Parpart as director, approval of an Employee Stock Option Plan, and consolidation of capital. All resolutions were approved by greater than 50% of shareholders present by polls, making this a clear shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-12
Item 5.07
This 8-K Item 5.07 discloses the results of the Company's Annual Meeting of Stockholders held on June 11, 2026, reporting the election of four directors (Andrey Semechkin, Russell Kern, Donald A. Wright, and Paul V. Maier) with vote tallies showing overwhelming support. Director elections are material governance events affecting the composition of the board and thus the registrant's oversight and strategic direction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Praxis Precision Medicines' 2026 Annual Meeting of Stockholders held on June 10, 2026. The filing presents voting results for three proposals: election of Class III directors (Gregory Norden, Marcio Souza, and William Young), ratification of Ernst & Young LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities, making this a material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This Item 5.07 discloses the results of Optimum Communications' 2026 Annual Meeting of Stockholders held on June 10, 2026, including voting tallies for the election of nine directors (Patrick Drahi, David Drahi, Dexter Goei, Dennis Mathew, Mark Mullen, Dennis Okhuijsen, Susan Schnabel, Charles Stewart, and Raymond Svider) and ratification of KPMG LLP as independent auditor. The detailed vote counts for and against each proposal are provided, making this a clear shareholder_vote_results disclosure. Board composition and auditor ratification are material to investors' assessment of governance and financial oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from AbCellera's Annual Meeting of Shareholders held on June 11, 2026. The filing reports voting outcomes for three proposals: (i) election of two Class III directors (John S. Montalbano and Stephen R. Quake), (ii) ratification of Ernst & Young LLP as independent auditor, and (iii) advisory approval of named executive officer compensation. All three proposals were approved by shareholders, with detailed vote tallies provided for each. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
Angi Inc. held its Annual Meeting of Stockholders on June 10, 2026, with shareholders voting on three proposals: election of three Class II directors (Sandra Buchanan, Thomas C. Pickett Jr., and Glenn H. Schiffman), approval of the amended and restated 2017 Stock Plan, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with disclosed vote tallies.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
Stockholders voted at the Annual Meeting on four proposals: election of six directors, advisory vote on executive compensation, approval of the Third Amended and Restated Omnibus Incentive Plan (increasing share pool by 2.5 million shares and extending the plan to 2036), and ratification of Grant Thornton as independent auditor. All proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Arcus Biosciences' June 11, 2026 annual meeting, covering three proposals: election of Class II directors (Dietmar Berger, David Lacey, Nicole Lambert, and Johanna Mercier), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed vote tallies (votes for, against, withheld, abstentions, and broker non-votes) for each proposal, which is the standard format for Item 5.07 disclosures and constitutes material information about corporate governance outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Opendoor's 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing reports voting outcomes for three proposals: election of three Class III directors (David Benson, Eric Feder, Eric Wu), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Clover Health's June 10, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies on three proposals: election of three Class II directors (Kouzoukas, Toy, and Tran), a non-binding advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with substantial majorities. Shareholder meeting outcomes are material to investors as they determine board composition and affirm key governance decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from LENZ Therapeutics' 2026 annual meeting held on June 12, 2026. The filing reports voting outcomes for two matters: (1) election of three Class II directors (Evert Schimmelpennink, Jeff George, and Shelley Thunen), and (2) ratification of Ernst & Young LLP as independent auditor. The tabulated vote counts for each nominee and proposal are the core content of Item 5.07, which is the standard Item for reporting annual meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This Item 5.07 disclosure reports the results of Playtika's annual meeting of stockholders held on June 11, 2026, including voting outcomes for three proposals: election of six directors, ratification of the independent auditor (Kost Forer Gabbay & Kasierer), and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a standard shareholder vote results disclosure that is material to investors' understanding of corporate governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Enovix's 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing presents voting outcomes for three proposals: election of eight directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three proposals were approved by stockholders with detailed vote tallies (For, Against, Abstain, and Broker Non-Votes). This is a material disclosure as it documents shareholder approval of the board composition and executive compensation arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Coupang's June 11, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on three proposals: (1) election of seven directors, (2) ratification of Samil PricewaterhouseCoopers as independent auditor, and (3) advisory approval of named executive officer compensation. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Krispy Kreme's June 10, 2026 annual meeting. The filing presents detailed voting tallies for four proposals: election of eight directors, advisory approval of executive compensation, ratification of Grant Thornton LLP as auditor, and approval of the 2021 Omnibus Incentive Plan amendment. All proposals passed with substantial majorities, making this a material governance event that investors rely on to assess board composition and compensation oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder voting results from Lineage's June 9, 2026 annual meeting of stockholders. The filing presents final vote tallies for three proposals: (i) election of all ten director nominees, (ii) ratification of PricewaterhouseCoopers LLP as independent auditor, and (iii) advisory approval of named executive officer compensation. This is the quintessential Item 5.07 disclosure and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Portillo's 2026 Annual Meeting of Shareholders held on June 9, 2026. The filing reports final voting tallies for three proposals: (i) election of seven directors, (ii) advisory approval of Named Executive Officer compensation, and (iii) ratification of Deloitte & Touche LLP as independent auditor. This is a textbook Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-06-12
The filing announces a general meeting of shareholders scheduled for 23 July 2026 to vote on a proposed $2.0 billion share repurchase programme previously approved by the Board on 7 May 2026. While this is technically a notice of a future shareholder vote rather than results of a completed vote, the disclosure of a material shareholder action (approval of a significant capital allocation program) is a governance event that would affect investor assessment. The $2.0bn repurchase is material to the company's capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-12
EX-99.1
The exhibit discloses results of an Extraordinary General Meeting held on 11 June 2026, with shareholder approval of three resolutions: agenda approval, dividend payment of KZT 850 per share for 1Q 2026, and election of three members to the Counting commission. This is a classic shareholder vote result disclosure (Item 5.07 equivalent), material because it announces a dividend distribution and governance appointments approved by shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This Item 5.07 filing discloses the final voting results from MercadoLibre's Annual Meeting of Stockholders held on June 9, 2026. The section presents detailed vote tallies for three proposals: election of Class I directors (with individual vote counts for each nominee), advisory approval of named executive officer compensation, and ratification of the independent auditor (Pistrelli, Henry Martin y Asociados S.A.). All three proposals passed. This is a standard shareholder vote results disclosure that materially informs investors of governance outcomes and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of American Integrity Insurance Group's annual meeting of stockholders held on June 11, 2026. The filing presents voting results for four proposals: election of director Steven Smathers, ratification of Forvis Mazars as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. All proposals received sufficient votes for approval. This is material as it documents stockholder actions on governance and audit matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This 8-K Item 5.07 discloses the results of Medline Inc.'s 2026 Annual Meeting of Stockholders held on June 11, 2026, including voting outcomes on four matters: election of 12 directors, advisory approval of executive compensation, frequency of advisory compensation votes (approved for annual frequency), and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies for each director and each proposal are provided, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from TJX's annual meeting held June 9, 2026, covering three proposals: election of ten directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final vote tallies (For, Against, Abstaining, Broker Non-Votes) for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-11
Item 5.07
Flagstar Bank held its Annual Meeting of Shareholders on June 9, 2026, with voting results on four proposals: election of eight directors, ratification of KPMG LLP as auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2020 Omnibus Incentive Plan increasing reserved shares by 12,000,000. All proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This Item 5.07 filing discloses the final results of Freshpet's 2026 Annual Meeting of Stockholders held on June 10, 2026, including voting outcomes for three proposals: (1) election of 12 directors, (2) ratification of KPMG LLP as independent auditor, and (3) non-binding advisory vote on named executive officer compensation. The detailed vote tallies for each director and proposal are the core disclosure, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from the Annual Meeting of Stockholders held on June 11, 2026, covering four proposals: election of directors, say-on-pay advisory vote, equity plan amendment, and auditor ratification. Item 5.07 is the designated 8-K item for shareholder vote results, and the filing presents final vote tallies for each matter, which is material to investors' understanding of corporate governance and executive compensation approval.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from Annaly's 2026 Annual Meeting of Stockholders held on June 10, 2026. The filing reports final voting tallies for four proposals: election of nine directors, advisory approval of executive compensation, ratification of Ernst & Young LLP as auditor, and rejection of a written consent proposal. The detailed vote counts for each director and proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →